Block orexin — the brain's wake-promoting neuropeptide. Rather than sedating the central nervous system, these drugs turn down the wake signal itself, which produces a sleep architecture that more closely resembles natural sleep than older hypnotics.
Approved for long-term use in chronic insomnia — the first class ever approved for that indication. Common side effects include next-day somnolence and, rarely, sleep paralysis or complex sleep behaviors. Schedule IV controlled substances.